Correctional Health Care, Reentry & Diversion Services

The corrections health care, re-entry, and diversion market is defined as the provision of medical and behavioural health services to the incarcerated, services to ease the transition back into the community, and diversion services related to decreasing or avoiding jail time for certain offences. The corrections market faces a number of challenges including the high number of individuals with serious mental illness, an increasingly female population, providing adequate care, and helping former inmates adapt and succeed in the community.

Latest Resources

• Kentucky Launches Medicaid Reentry Coverage For Individuals Preparing For Release From State Custody
• Alabama DOC Terminates YesCare’s $1.06 Billion Prison Health Care Contract & Selects NaphCare As Replacement
• Reinventing Mobile Crisis
• Missouri Enacts Sentencing Reform Law Establishing Minimum Time Served Requirements
• Missouri Senate Bill 882: Modifies Provisions Relating To Criminal Offenses, Including Minimum Prison Terms & Conditional Release
• Oklahoma Fails To Meet Consent Decree Requirements On Timely Competency Restoration
• Wyoming Rebids Jail & Community Corrections IOP Addiction Treatment Contracts With July 2026 Start
• Half Of U.S. Jails Are More Than 30 Minutes From Opioid Treatment Programs, Limiting MOUD Access
• U.S. Reincarceration Rates Fall To 28%, With 30,000 Fewer Annual Returns To Prison
• The Evolution Of Crisis Response Systems: An OPEN MINDS Roundtable On Harris County’s Collaborative CORE Model
• The Change Companies & ViaPath Collaborate To Expand Digital Behavioral Health Programming In Correctional Facilities
• New York Bars NaphCare From Correctional Health Contracts For Five Years Following Corporate Practice Of Medicine Violations
• Breaking the Revolving Door: How an Intensive Crisis Stabilization Center Is Reducing ER Reliance
• Are You CCBHC-Ready? Preparing for the 2026 SAMHSA Funding Cycle
• Hamilton County, Tennessee Jail & Detention Center Launches Medication-Assisted Treatment Program

See All

Monthly Injectable Buprenorphine May Reduce Staffing Time & Costs For OUD Treatment In Correctional Settings, Simulation Finds

A monthly injectable formulation of extended-release buprenorphine may reduce staffing time and associated costs for treating opioid use disorder (OUD) in correctional settings, according to a simulation model. The model estimated staffing time and costs required to administer medications for opioid use disorder (MOUD) to 100 incarcerated individuals per month. Monthly hours for clinical professionals to administer and observe dosing and for security staff to accompany inmates ranged from 63 hours for Sublocade (17 clinical… Read

• Ohio Attorney General Awards 30 More Grants Supporting Addiction Treatment For Inmates
• CFG Health Launches CareLink, A Fully Integrated, 24/7 Telehealth Platform For Correctional Health Care
• Crisis Reorg
• Pennsylvania Awards $2 Million To Centre County To Improve Juvenile Justice Services, Combat Opioid Addiction, Strengthen Programs For Crime Survivors
• Topeka Correctional Facility In Kansas Launches Community Health Worker Development Reentry Program

To sign-up for monthly Justice-Involved & Corrections Support Services alerts, you must be signed in to your account.